170 related articles for article (PubMed ID: 33542599)
21. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
22. External beam radiation "salvage" therapy in transgenic murine retinoblastoma.
Sobrin L; Hayden BC; Murray TG; Cicciarelli N; Scott IU; Hernandez E; Wu X; Markoe AM; Feuer W; Fulton L; O'Brien JM
Arch Ophthalmol; 2004 Feb; 122(2):251-7. PubMed ID: 14769602
[TBL] [Abstract][Full Text] [Related]
23. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
[TBL] [Abstract][Full Text] [Related]
24. Current treatment of retinoblastoma.
De Potter P
Curr Opin Ophthalmol; 2002 Oct; 13(5):331-6. PubMed ID: 12218465
[TBL] [Abstract][Full Text] [Related]
25. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
26. Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma.
Yousef YA; Al Jboor M; Mohammad M; Mehyar M; Toro MD; Nazzal R; Alzureikat QH; Rejdak M; Elfalah M; Sultan I; Rejdak R; Al-Hussaini M; Al-Nawaiseh I
Front Pharmacol; 2021; 12():696787. PubMed ID: 34322023
[No Abstract] [Full Text] [Related]
27. External beam irradiation for choroid metastases: identification of factors predisposing to long-term sequelae.
Rudoler SB; Corn BW; Shields CL; De Potter P; Hyslop T; Shields JA; Curran WJ
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):251-6. PubMed ID: 9226310
[TBL] [Abstract][Full Text] [Related]
28. Chemoreduction of Progressive Intraocular Retinoblastoma by Systemic Topotecan.
Sultan I; Hajja Y; Nawaiseh I; Mehyar M; Deebajah R; Jaradat I; Yousef YA
Ophthalmic Genet; 2016 Jun; 37(2):209-13. PubMed ID: 26760494
[TBL] [Abstract][Full Text] [Related]
29. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria.
Sovinz P; Urban C; Lackner H; Benesch M; Langmann G
Wien Klin Wochenschr; 2006 Feb; 118(1-2):22-30. PubMed ID: 16489522
[TBL] [Abstract][Full Text] [Related]
30. Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma.
Liang TY; Zhu XY; Hua XM; Ji XD; Zhao PQ
Int J Ophthalmol; 2020; 13(2):257-262. PubMed ID: 32090035
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma.
Yousef YA; Noureldin AM; Sultan I; Deebajah R; Al-Hussaini M; Shawagfeh M; Mehyar M; Mohammad M; Jaradat I; AlNawaiseh I
J Ophthalmol; 2020; 2020():8628525. PubMed ID: 32047663
[TBL] [Abstract][Full Text] [Related]
32. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
Say EA; Iyer PG; Hasanreisoglu M; Lally SE; Jabbour P; Shields JA; Shields CL
J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850
[TBL] [Abstract][Full Text] [Related]
33. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
Gündüz K; Shields CL; Shields JA; Meadows AT; Gross N; Cater J; Needle M
Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
[TBL] [Abstract][Full Text] [Related]
34. External beam radiation for retinoblastoma: results, patterns of failure, and a proposal for treatment guidelines.
Hernandez JC; Brady LW; Shields JA; Shields CL; DePotter P; Karlsson UL; Markoe AM; Amendola BE; Singh A
Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):125-32. PubMed ID: 8641908
[TBL] [Abstract][Full Text] [Related]
35. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
[TBL] [Abstract][Full Text] [Related]
36. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.
Sussman DA; Escalona-Benz E; Benz MS; Hayden BC; Feuer W; Cicciarelli N; Toledano S; Markoe A; Murray TG
Arch Ophthalmol; 2003 Jul; 121(7):979-84. PubMed ID: 12860801
[TBL] [Abstract][Full Text] [Related]
37. Globe salvage using chemoreduction for advanced retinoblastoma in a glaucomatous eye with buphthalmos.
Parvus BJ; Salazar PF; Shields CL; Shields JA
Retin Cases Brief Rep; 2009; 3(1):1-3. PubMed ID: 25390824
[TBL] [Abstract][Full Text] [Related]
38. Retinoblastoma in Turkey: results from a tertiary care center in Ankara.
Gündüz K; Köse K; Kurt RA; Süren E; Taçyildiz N; Dinçaslan H; Ünal E; Erden E; Heper AO
J Pediatr Ophthalmol Strabismus; 2013; 50(5):296-303. PubMed ID: 23937863
[TBL] [Abstract][Full Text] [Related]
39. Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras.
Selzer EB; Welch RJ; Jabbour P; Leahey AM; Shields CL
Indian J Ophthalmol; 2019 Dec; 67(12):2005-2011. PubMed ID: 31755439
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
